• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OBERDORF SYNTHES PRODUKTIONS GMBH BOLT Ø4.9 SELF-TAP L34 TAV GREEN; ROD, FIXATION, INTRAMEDULLARY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OBERDORF SYNTHES PRODUKTIONS GMBH BOLT Ø4.9 SELF-TAP L34 TAV GREEN; ROD, FIXATION, INTRAMEDULLARY Back to Search Results
Catalog Number 459.340VS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
Occupation: synthes employee.Device is not distributed in the united states but is similar to device marketed in the usa.The investigation could not be completed, no product was received; no conclusion could be drawn at the time of filing this report.(b)(4).Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Device report from synthes reports an event in (b)(6) as follows: it was reported that in (b)(6) 2018, the patient underwent an implant surgery for femoral sub-trochanteric fracture with the pfna and the nail was break on (b)(6) 2019.The hospital followed up the patient without any removal surgery, but the fracture part didn¿t unite.In (b)(6) 2019, the nail broke at the fracture part due to non-union.The day after that, the patient underwent re-operation, and the re-operation was completed successfully.The fracture was atypical fracture, and it caused non-union and the breakage of the nail.This is report 3 of 3 for (b)(4).Related product complaints: (b)(4).
 
Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device history lot part: 459.340vs, lot: 5939410, manufacturing site: salzburg, release to warehouse date: july 05, 2016, expiry date: june 01, 2026.A manufacturing record evaluation was performed for the finished device lot number, and no non-conformances were identified.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BOLT Ø4.9 SELF-TAP L34 TAV GREEN
Type of Device
ROD, FIXATION, INTRAMEDULLARY
Manufacturer (Section D)
OBERDORF SYNTHES PRODUKTIONS GMBH
eimattstrasse 3
oberdorf 4436
SZ  4436
MDR Report Key9511715
MDR Text Key186602928
Report Number8030965-2019-71375
Device Sequence Number1
Product Code HSB
UDI-Device Identifier07611819702523
UDI-Public(01)07611819702523
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number459.340VS
Device Lot Number5939410
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/03/2019
Initial Date FDA Received12/23/2019
Supplement Dates Manufacturer Received12/26/2019
Supplement Dates FDA Received01/17/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-